Synergistic Heart Valve Replacement System

Publication ID: 24-11857413_0008_PTD

Published: October 28, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Heart Valve Replacement System,” Published Technical Disclosure No. 24-11857413_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857413_0008_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,413.

Summary of the Inventive Concept

The Synergistic Heart Valve Replacement System integrates a prosthetic heart valve with advanced technologies like AI, IoT, blockchain, and nanomaterials to create a more efficient, personalized, and secure system for heart valve replacement.

Background and Problem Solved

The original patent for a stented prosthetic heart valve with variable stiffness addressed the need for a more effective heart valve replacement system. However, it had limitations in terms of real-time monitoring, data security, and personalized design. The Synergistic Heart Valve Replacement System solves these problems by incorporating advanced technologies to enhance the overall system.

Detailed Description of the Inventive Concept

The system consists of a prosthetic heart valve with a stent frame, a sensor for monitoring heart valve function, and a blockchain-based data storage system for securely storing patient data. The system can also include AI and machine learning algorithms to analyze data from the sensor and adjust the stent frame configuration accordingly. Additionally, the stent frame can be made of a shape memory alloy and integrated with an IoT-enabled device for real-time monitoring and control of valve function. The system can also include a nanomaterial-based coating for enhanced biocompatibility and a data analytics platform for predicting patient outcomes. The system can be further personalized using 3D printing and machine learning algorithms to create customized stent frames based on individual patient anatomy.

Novelty and Inventive Step

The new claims introduce novel combinations of advanced technologies like AI, IoT, blockchain, and nanomaterials with the original prosthetic heart valve concept, providing a more efficient, personalized, and secure system for heart valve replacement. The inventive step lies in the integration of these distinct technologies to create a synergistic system that overcomes the limitations of the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the Synergistic Heart Valve Replacement System could include the use of different AI algorithms, varying IoT device configurations, or alternative nanomaterial-based coatings. The system could also be adapted for use in other medical applications, such as vascular stents or implantable devices.

Potential Commercial Applications and Market

The Synergistic Heart Valve Replacement System has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular disease treatment and personalized medicine. The system's advanced features and improved outcomes could lead to increased adoption and market share.

CPC Classifications

Section	Class	Group
A	A61	A61F2/2418
A	A61	A61F2250/0018
A	A61	A61F2250/0029

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Medical device engineering, specifically cardiovascular implant technologies with a focus on prosthetic heart valve design and advanced medical monitoring systems

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with expertise in medical device design, interventional cardiology technologies, materials science, and advanced sensor/monitoring systems, holding advanced degrees and practical experience in developing implantable medical devices

Obviousness Rationale

A person having ordinary skill in the art would recognize that integrating advanced monitoring technologies with prosthetic heart valve designs represents a predictable extension of existing medical device innovation. The combination of sensor technologies, data analytics, and personalized medical device design are well-established trends in medical engineering. The PTD's proposed variations represent logical technological progressions that would be obvious to a skilled practitioner seeking to enhance prosthetic heart valve performance and patient outcomes.

Obvious Combinations & Variations

Source Patent Element

Stented prosthetic heart valve with expandable stent frame

PTD Variation

Incorporating shape memory alloy materials and IoT-enabled monitoring capabilities into the stent frame

Obviousness Reasoning

Material selection and integration of smart monitoring technologies are predictable design improvements in medical device engineering, representing a known technique for enhancing device functionality

Source Patent Element

Heart valve replacement method involving precise anatomical positioning

PTD Variation

Using machine learning algorithms and 3D printing to customize stent frame geometry based on individual patient anatomy

Obviousness Reasoning

Personalized medical device design is a recognized approach in modern medical engineering, representing a finite and predictable solution for improving implant performance

Source Patent Element

Prosthetic heart valve with radiopaque markers for positioning

PTD Variation

Implementing blockchain-based secure data storage and analytics platform for patient monitoring

Obviousness Reasoning

Integrating advanced data management technologies into medical device systems is a known technique for improving patient care and device tracking

Source Patent Element

Stent frame configured for expansion and deployment

PTD Variation

Adding nanomaterial-based biocompatibility coatings to enhance tissue integration

Obviousness Reasoning

Surface modification techniques using nanomaterials are well-established in medical device design for improving biocompatibility and performance

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857413 and the published technical disclosure, a person having ordinary skill in the art would find the proposed variations of prosthetic heart valve technologies to be obvious combinations of known medical device design principles. The integration of AI, IoT, blockchain, and nanomaterial technologies represents predictable extensions of existing cardiovascular implant engineering approaches, thereby rendering potential patent claims obvious and anticipatable as prior art.

Original Patent Information

Patent Number	US 11,857,413
Title	Stented prosthetic heart valve with variable stiffness and methods of use
Assignee(s)	Medtronic Vascular Galway